Vetnostrum Animal Health Co (TPE:6936) Notes Receivable: NT$0 Mil (As of Dec. 2025)


TPE:6936 Vetnostrum Animal Health Co Ltd TPE:6936
67 GF Score
Price NT$33.00
GF Value NT$39.80
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Vetnostrum Animal Health Co Notes Receivable?

Vetnostrum Animal Health Co TPE:6936 +0.30% 67 Notes Receivable is NT$0 Mil as of Dec. 2025. GuruFocus rates TPE:6936 with a GF Score™ of 67/100 and a GF Value™ of NT$39.80 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Vetnostrum Animal Health Co's Notes Receivable for the quarter that ended in Dec. 2025 was NT$0 Mil.

Vetnostrum Animal Health Co Notes Receivable Related Terms

Vetnostrum Animal Health Co Notes Receivable Historical Data

* Premium members only.

The historical data trend for Vetnostrum Animal Health Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vetnostrum Animal Health Co Notes Receivable Chart

Vetnostrum Animal Health Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Vetnostrum Animal Health Co Quarterly Data
Dec18 Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TPE:6936
67GF Score
Vetnostrum Animal Health Co Ltd TPE:6936
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vetnostrum Animal Health Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of NT$0 Mil mean?
Vetnostrum Animal Health Co (TPE:6936) has a Notes Receivable of NT$0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Vetnostrum Animal Health Co and its competitors.
Is Vetnostrum Animal Health Co's Notes Receivable too high?
Vetnostrum Animal Health Co's current Notes Receivable is NT$0 Mil. Overall, Vetnostrum Animal Health Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vetnostrum Animal Health Co's Notes Receivable compare to ADM and BG?
Vetnostrum Animal Health Co's Notes Receivable of NT$0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Consumer Packaged Goods company?
A good Notes Receivable depends on the Consumer Packaged Goods industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Vetnostrum Animal Health Co and its competitors. Vetnostrum Animal Health Co's current Notes Receivable is NT$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vetnostrum Animal Health Co stock overvalued right now?
Based on GuruFocus' analysis, Vetnostrum Animal Health Co (TPE:6936) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$39.80, compared to a current price of NT$33.00 — trading 17.1% below its estimated fair value. The current Notes Receivable is NT$0 Mil. Vetnostrum Animal Health Co's overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Vetnostrum Animal Health Co (TPE:6936), the current Notes Receivable is NT$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vetnostrum Animal Health Co (TPE:6936) Overvalued in 2026?

Based on GuruFocus' analysis, Vetnostrum Animal Health Co stock appears to be undervalued. The current stock price of NT$33.00 is trading 17.1% below its estimated GF Value™ of NT$39.80. GuruFocus considers Vetnostrum Animal Health Co to be Modestly Undervalued.

Key valuation signals for TPE:6936:

  • Notes Receivable: NT$0 Mil
  • GF Value™: NT$39.80 vs. price of NT$33.00 (17.1% below fair value)
  • GF Score™: 67/100 with 1 warning sign

No single metric tells the full story. See the TPE:6936 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vetnostrum Animal Health Co Business Description

Address Chung Lun, No. 290-3, Chung Lun Village, Hsinfeng, Hsinchu County, Hsinchu, TWN, 30422
Vetnostrum Animal Health Co Ltd is mainly engaged in importing, manufacturing, and selling pharmaceuticals and nutrition supplements for animals, feed additives, and feed. It derives a majority of its revenue from the sale of animal pharmaceuticals, medicated feed additives, and feeds and the rendering of drug testing services. Geographically, the company derives maximum revenue from Taiwan, followed by the USA, Malaysia, and other countries.
67GF Score

Get the complete analysis for TPE:6936

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$33.00
Price
NT$39.80
GF Value